Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era-Reference-Cited by-同舟云学术

Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era

Published:2021-03-22 Issue:9 Volume:62 Page:2253-2260
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pemmaraju Naveen¹^ORCID,Wilson Nathaniel R.²^ORCID,Clementi Doan Theresa³,Qiao Wei¹,Peterson Susan K.¹,Zoeller Vicky¹,Schorr Andrew³,Verstovsek Srdan¹^ORCID

Affiliation:

1. The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

2. The University of Texas Health Science Center at Houston, Houston, TX, USA

3. Patient Power, LLC, Bellevue, WA, USA

Funder

University of Texas MD Anderson Cancer Center

SagerStrong Foundation.

SagerStrong Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1901096

Reference36 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Myeloproliferative Neoplasms

3. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

2. Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature;British Journal of Haematology;2024-06-10

3. Implementing Telemedicine in Clinical Practice in the First Digital Hematology Unit: Feasibility Study;JMIR Formative Research;2023-12-04

4. Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers;Blood Advances;2023-09-29

5. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need;Blood;2023-02-09